Contract Research Organization Market Size to Hit USD 133.2 Billion by 2032 | MRFR

Market Research Future (MRFR) has published a cooked research report on the “Global Contract Research Organization Market” that contains information from 2018 to 2032. The Contract Research Organization market is estimated to register a CAGR of 12.01% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global Contract Research Organization market— ICON, Laboratory Corporation of America Holdings, PRA health science, IQVIA, PPD Inc, Med pace, Envigo, Charles River Laboratories, Paracel international company.

Contract Research Organization Market Highlights

The global Contract Research Organization market is accounted to register a CAGR of 12.01% during the forecast period and is estimated to reach USD 133.2 Billion by 2032.

The Contract Research Organization (CRO) market is a sector that provides outsourced research services to the pharmaceutical, biotechnology, and medical device industries. CROs offer expertise in conducting clinical trials, data management, regulatory support, and other research-related services to help companies accelerate the development of new drugs and therapies.

Segment Analysis

The global Contract Research Organization market has been segmented based on Type, Clinical Trial Phase and End-User.

On the basis of Type, the market is segmented into Drug Discovery, Clinical Development. In terms of revenue, the worldwide Contract Research Organisation (CRO) market was dominated by the Drug Discovery sector in 2021. This section comprises drug discovery-related services like target validation, hit-to-lead, and lead optimisation.

Based on Clinical Trial Phase, the global Contract Research Organization market has been segmented into Preclinical Trials, Phase I, Phase II, Phase III, Phase IV, and Others. During the anticipated period, 2022-2030, the preclinical trials sector had the majority of the market share in 2021. This is a result of the pharmaceutical and biotechnology sectors' rising demand for preclinical trial services. Before new medications and treatments are tried on people, preclinical studies are carried out to determine their safety and effectiveness.

Based on End User, the global Contract Research Organization market has been segmented into  market segmentation includes Academic institutes, pharmaceutical companies, and medical service companies. The pharmaceutical firms category dominated the market in 2021 and is anticipated to grow at the fastest rate from 2022 to 2030. The growing elderly population, rising prevalence of chronic diseases, and rising uptake of innovative medicines are all contributing reasons to the growth of this market segment. These variables have a favourable effect on the growth of the Contract Research Organisation (CRO) market.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Contract Research Organization Market Trends Report

Regional Analysis

The global Contract Research Organization market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Contract Research Organization market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Contract Research Organization market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Contract Research Organization market comprises of Middle East, Africa, and Latin America.

The North America Contract Research Organization Market dominated this market in 2022 The primary drivers propelling the growth of the CRO market in North America are the expanding pharmaceutical and biotechnology sectors in this area. The US CRO market is expanding as a result of the abundance of clinical research facilities as well as the accessibility of cutting-edge facilities and technology. The second-largest market in North America for CROs is Canada.

Additionally, the second-largest market share for Contract Research Organization is held by Europe’s. The market is fueled by the rising demand for outsourced clinical research services, the expansion of clinical trials in the area, and the accessibility of infrastructure and qualified labour.

Moreover, The Contract Research Organisation (CRO) market is anticipated to expand at the quickest CAGR in the Asia Pacific region. This is brought on by the region's expanding pharmaceutical and biotechnology industries as well as the rising number of clinical trials being carried out there.

Key Findings of the Study

• The global Contract Research Organization market is expected to reach USD 133.2 Billion by 2032, at a CAGR of 12.01% during the forecast period.


• The North America Contract Research Organization Market dominated this market in 2022 The primary drivers propelling the growth of the CRO market in North America are the expanding pharmaceutical and biotechnology sectors in this area.


• Based on Type, the worldwide Contract Research Organisation (CRO) market was dominated by the Drug Discovery sector in 2021.


• ICON, Laboratory Corporation of America Holdings, PRA health science, IQVIA, PPD Inc, Med pace, Envigo, Charles River Laboratories, Paracel international company.